Drug Safety

3.3(top 10%)

impact factor

3.3K(top 10%)

papers

124.6K(top 5%)

citations

144(top 2%)

h-index

3.7(top 10%)

impact factor

4.0K

all documents

131.0K

doc citations

200(top 5%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	Under-Reporting of Adverse Drug Reactions	Drug Safety	2006	1,313
2	The Medical Dictionary for Regulatory Activities (MedDRA)	Drug Safety	1999	850
3	Cardiotoxicity of Chemotherapeutic Agents	Drug Safety	2000	606
4	Use of Screening Algorithms and Computer Systems to Efficiently Signal Higher-Than-Expected Combinations of Drugs and Events in the US FDA??s Spontaneous Reports Database	Drug Safety	2002	508
5	Determinants of Under-Reporting of Adverse Drug Reactions	Drug Safety	2009	446
6	Drug-Related Problems in Hospitals	Drug Safety	2007	444
7	Drug-Induced Liver Injury Network (DILIN) Prospective Study	Drug Safety	2009	416
8	Antimalarial Drug Toxicity	Drug Safety	2004	406
9	Principles of Data Mining	Drug Safety	2007	405
10	Post-Transplant Malignancy	Drug Safety	2000	355
11	Benefits and Risks of Self Medication	Drug Safety	2001	354
12	Causes of Medication Administration Errors in Hospitals: a Systematic Review of Quantitative and Qualitative Evidence	Drug Safety	2013	331
13	Adverse Effects of Bisphosphonates	Drug Safety	1996	321
14	Panax ginseng	Drug Safety	2002	318
15	Epidemiology of Adverse Drug Reactions in Europe: A Review of Recent Observational Studies	Drug Safety	2015	310
16	Anticancer Drug???Induced Kidney Disorders	Drug Safety	2001	309
17	The Relationship between Number of Drugs and Potential Drug-Drug Interactions in the Elderly	Drug Safety	2007	309
18	Individual NSAIDs and Upper Gastrointestinal Complications	Drug Safety	2012	308
19	Harmonisation in Pharmacovigilance	Drug Safety	1994	303
20	Drug-Induced Liver Injury	Drug Safety	2007	303
21	Prevalence, Incidence and Nature of Prescribing Errors in Hospital Inpatients	Drug Safety	2009	302
22	Effects of Psychotropic Drugs on Seizure Threshold	Drug Safety	2002	301
23	Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature	Drug Safety	2018	301
24	Drug-Induced Cutaneous Photosensitivity	Drug Safety	2002	299
25	Cholinesterase Inhibitors in the Treatment of Alzheimer??s Disease	Drug Safety	1998	295
26	Methods for Causality Assessment of Adverse Drug Reactions	Drug Safety	2008	295
27	Safety of Non-Antiarrhythmic Drugs that Prolong the QT Interval or Induce Torsade de Pointes	Drug Safety	2002	291
28	Orlistat-Associated Adverse Effects and Drug Interactions	Drug Safety	2008	289
29	Adverse Gastrointestinal Effects of Mycophenolate Mofetil	Drug Safety	2001	288
30	Risks and Benefits of Nicotine to Aid Smoking Cessation in Pregnancy	Drug Safety	2001	286
31	Tolerability of Atypical Antipsychotics	Drug Safety	2000	281
32	Locally Administered Ocular Corticosteroids	Drug Safety	2002	275
33	Anticonvulsant Hypersensitivity Syndrome	Drug Safety	1999	274
34	Comparative Adverse Effect Profiles of Platinum Drugs	Drug Safety	1995	271
35	Safety of Green Tea Extracts	Drug Safety	2008	271
36	Evaluation of Drug-Induced QT Interval Prolongation	Drug Safety	2001	253
37	Aristolochic Acid and ???Chinese Herbs Nephropathy???	Drug Safety	2003	251
38	HMG-CoA Reductase Inhibitors and Myotoxicity	Drug Safety	2000	249
39	A Benefit-Risk Assessment of Benzbromarone in the Treatment of Gout	Drug Safety	2008	243
40	Digital Drug Safety Surveillance: Monitoring Pharmaceutical Products in Twitter	Drug Safety	2014	241
41	Cardiovascular Effects of Methylphenidate, Amphetamines and Atomoxetine in the Treatment of Attention-Deficit Hyperactivity Disorder	Drug Safety	2010	240
42	Clinical Toxicity of the Interferons	Drug Safety	1994	238
43	Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs	Drug Safety	2015	238
44	A Risk-Benefit Assessment of Flumazenil in the Management of Benzodiazepine Overdose	Drug Safety	1997	234
45	Drug-Induced Liver Disorders	Drug Safety	2001	233
46	Traditional Remedies and Food Supplements	Drug Safety	1997	228
47	Drug-Induced Methaemoglobinaemia Treatment Issues	Drug Safety	1996	222
48	Systemic Antifungal Agents	Drug Safety	1998	222
49	Clarification of Terminology in Drug Safety	Drug Safety	2005	221
50	Negative Effects of Antiepileptic Drugs on Mood in Patients with Epilepsy	Drug Safety	2007	220

Scientometrics

Overviews

Citing Bodies

Drug Safety

Top Articles